Thursday, August 8, 2013

HoLEP Safe, Effective After Failed BPH Surgery



Holmium laser enucleation of the prostate (HoLEP) is safe and effective for easing persistent lower urinary tract symptoms after failed prior surgery for benign prostatic hyperplasia (BPH), researchers concluded

According to the survey,These patients were matched according to preoperative prostate size to 74 patients who underwent HoLEP but did not have prior surgery (group II).Results showed that both groups had significant and similar improvements in peak flow rate and post-void residual (PVR).study demonstrates similar efficacy and incidence of complications regardless of prior transurethral prostate surgery.

Wednesday, August 7, 2013

Fish Oil May Raise Prostate Cancer Risk



Increased intake of omega-3 fatty acids, which is widely promoted as a way to prevent cardiovascular disease and cancer, may increase the risk of prostate cancer (PCa), especially aggressive disease, according to a study.

The SELECT trial enrolled 35,533 men who were randomly assigned to take vitamin E alone, selenium alone, and vitamin E in combination with selenium. Results showed that men who took vitamin E alone had a significant 17% increased risk of PCa compared with placebo recipients after a total follow-up of seven years.

One potentially harmful effect of omega-3 fatty acids is their conversion into compounds that can cause damage to cells and DNA.


Tuesday, August 6, 2013

Greater Physical Activity Lowers Kidney Stone Risk


Physical activity may lower the risk of kidney stones in women, researchers reported at the American Urological Association 
According to the survey ,84,225 post menopausal women aged 50-79 enrolled

Incidence kidney stones were reported by 2,392 women (2.8%). Women in the lowest physical activity category had a 14% decreased risk of kidney stones compared with sedentary women in adjusted analyses.

The study also showed that greater dietary energy intake was associated with up to a 44% increased risk of incident kidney stones. Lower dietary energy intake, however, did not protect against stone formation. 

Greater body mass index category increased the risk of incident stones.


Tadalafil Found to Ease Ejaculatory Problems


Tadalafil (Cialis) may help to ease ejaculatory or orgasmic dysfunction in men with erectile dysfunction (ED), according to an analysis of data from 3,581 men enrolled in 17 randomized, placebo-controlled trials of the drug. 

In a study led by New York-Presbyterian Hospital/Weill Cornell Medical College in New York, 66% of tadalafil-treated subjects who had severe ejaculatory dysfunction reported improved ejaculatory function compared with 36% who received placebo. In addition, 66% of tadalafil-treated patients with severe orgasmic dysfunction reported improvement compared with 35% of placebo recipients. 

According to the Survey,18% of men have a normal erection but do not ejaculate or take a long time to do so., Non-erectile sexual dysfunction is under-reported and under treated because of social stigma as well as misunderstanding about the physiology of male sexual response and orgasmic dysfunction.

Monday, August 5, 2013

Our experience with Thulium LASER in patients on antiplatelet agents and anticoagulants


We operated 217 patients who were either on antiplatelet agents or anticoagulants. We did not hold on antiplatelet agents and those who were on anticoagulants were converted on heparin.

It has been noted that the most common complications in prostate surgery in more than 75 years of the age is cardiac causes. Fluid overload, pulmonary oedema, DVT, myocardial infarction etc. were the most common reasons for mortality.

As it has been seen that 30% of the patients with BPH have cardiac comorbidties. Most of the patients with cardiac ailments are now administered anti platelet agents either aspirin ( 81 mg/75 mg) or clopidogrel or combination of both. In view of elderly age , cardiac comorbidities, lithotomy position , immobilization during and after the surgery and the fluid overload because of the use of irrigation during the endoscopic prostatectomy withholding of antiplatelet agents or anticoagulants can be counterproductive.

TURP the present Gold standard is fraught with the risk of bleeding( some series have shown the bleeding after TURP is as high as 30%).Also TURP needs Glycine as the irrigant so resultant overload and TURP syndrome can decompensate already fragile cardiac system in elderly people.

The Thulium LASER is a continuous wave LASER ( 2 MICRON ).Its superior to electro cautery(TURP) both in terms of bleeding and resection. The continuous wave LASER is superior to Holmium LASER( the other LASER used commonly for prostatectomy) in terms of its ability to vaporize the prostate (in people who are more prone for bleeding and also finding suitable plane in large glands.

The patients were between the age group of 44-87 years. The data was collected from 2009 to the present.

We generally used spinal anaesthesia for most patients but 3 patients had to be given either general anesthesia (2 ) or local pudental block(1).

We used 24 Fr continuous flow resectoscope and 550 micron Fibre (Revolix 70 W thulium LASER).We preferred either vaporization or vaporesection methodology while tackling the prostate for the fear of bleeding . 


Out of 217 patients 112 were on aspirin,96 were on clopidogrel and 4 were on anticoagulants. 

Patients profile- 83 were on stent ,21 were post CABG while 5 were patients with valve replacement history. 

The mean gland size of 28 gm to 140 gm .Only 7 patients had post operative or intraoperative bleeding(3.2%).0.9% patients needed blood transfusion. The mean percentage fall in hemoglobin was 0.7 gm/dl.The patients with bleeding needed cystoscopy and clot evacuation.2 patients had delayed bleeding( 7 days to 4 weeks).For them appropriate antibiotic therapy was instituted and cystoscopy was done.4 patients had Acute Coronary Syndrome for which heparinisation and treatment in cardiac ICU was needed but they eventually recovered without further cardiac intervention. There were no mortality.



This shows that Thulium LASER prostatectomy is safe even in patients on antiplatelet agents and on anticoagulants.They should be properly evaluated preoperatively in terms of cardiac risk .We prefer to use vaporization or vaporesection with LASER for safety and we have found the risk ( cardiac or bleeding) ti be very low.